What Wall Street Titans Own
Airtime: Mon. May 17 2010 | 7:12 PM ET
A look into what the titans of Wall Street are buying, with CNBC’s Tyler Mathisen.
Similar Posts
Study Identifies Heart Risks in Glaxo's Avandia
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
Steve Schwarzman's Worst Move
Discussing the worst trade of an otherwise stellar career, with Steve Schwarzman, Blackstone Group’s chairman, CEO & co-founder.
Ken Langone's Economic Outlook
Insight on the economy, with Ken Langone, president of Invemed Associates and co-founder of Home Depot.
Tracking Durable Goods
Airtime: Wed. Oct. 27 2010 | 8:30 AM ET Insight on the latest durable goods numbers, with CNBC’s Rick Santelli and Ben Lichtenstein, tradersaudio.com.
The Battle for 3Par
Insight on whether HP and Dell are overpaying for the company, with Stephanie Link, TheStreet.com; Rick Munarriz, The Motley Fool and CNBC’s Herb Greenberg.
Awful Month on Wall Street; Stocks Close Below 200 DMA Line!
Friday marked Day 4 of a new rally attempt for the benchmark S&P 500 Index and Day 2 for the other major averages. That said, as long Tuesday’s lows are not breached in the S&P 500, the window is now opened for a proper follow-through day (FTD) to occur. However, if at anytime Tuesday’s S&P 500 Index lows are breached, then the day count will be reset. What does all of this mean for investors? Simple, the market remains in a correction which reiterates the importance of adopting a strong defense stance until a new rally is confirmed. Trade accordingly.
